首页 | 本学科首页   官方微博 | 高级检索  
检索        

单克隆抗体BDI-I导向的阿霉素白蛋白毫微球对人膀胱癌细胞的特异杀伤活性
引用本文:盛洁,山登布卡,谢蜀生,魏树礼.单克隆抗体BDI-I导向的阿霉素白蛋白毫微球对人膀胱癌细胞的特异杀伤活性[J].药学学报,1995,30(9):706-710.
作者姓名:盛洁  山登布卡  谢蜀生  魏树礼
作者单位:北京医科大学药剂学教研室,*北京免疫学教研室,北京 100083
摘    要:用化学偶联法将抗人膀胱癌单克隆抗体分子偶联到阿霉素白蛋白毫微球上,构建了一个有靶向杀伤性的免疫毫微球,即:阿霉素白蛋白载单克隆抗体毫微球(ADR-NP-Ab)。改变阿霉素毫微球和单克隆抗体的反应分子比,确定了制备该免疫毫微球的最佳条件。经免疫荧光检测及显微照像分析证明,免疫毫微球可有效地和人膀胱癌细胞结合。体外杀伤试验表明,此免疫毫微球对靶细胞EJ有高度特异杀伤活性,而对无关的人直肠癌Lovo细胞则无明显作用。

关 键 词:免疫毫微球  单克隆抗体  人膀胱癌
收稿时间:1995-01-16

STUDY ON THE SPECIFIC KILLING ACTIVITY OF ALBUMMIN NANOPARTICLES CONTAINING ADRIAMYCIN TARGETED BY MONOCLONAL ANTIBODY BDI-1TO HUMAN BLADDER CANCER CELLS
J Sheng,BK Samten,SS Xie and SLWei.STUDY ON THE SPECIFIC KILLING ACTIVITY OF ALBUMMIN NANOPARTICLES CONTAINING ADRIAMYCIN TARGETED BY MONOCLONAL ANTIBODY BDI-1TO HUMAN BLADDER CANCER CELLS[J].Acta Pharmaceutica Sinica,1995,30(9):706-710.
Authors:J Sheng  BK Samten  SS Xie and SLWei
Abstract:A highly specific immuno- nanoparticle(ADR-NP-Ab)has been constituted bychemically coupling a monoclonal antibody BDI-1 to albumin nanoparticle containing adriamycin(ADR-NP).Different molecular ratios of antibedy to ADR-NP were tried to determine the optimalcondition for preparing the immuno- nanoparticle. The results of immunoflurecence and micropho-tographic analysis showed that the activity of ADR-NP-Ab was well preserved. The result of thecytotoxicity cytotoxicity of ADR-NP-Ab in vitro assay showed strong killing activity of ADR-NP-Ab to bladdercancer cells(EJ) ,while no apparent cytotoxlc activity to non-targeted human colon carcinoma cells(Lovo)was observed.
Keywords:BK Samten  SS Xie and SLWei  J Sheng
本文献已被 维普 等数据库收录!
点击此处可从《药学学报》浏览原始摘要信息
点击此处可从《药学学报》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号